Atlas Trials

Wuhan General Hospital of Guangzhou Military Command

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Wuhan General Hospital of Guangzhou Military Command

RecordFirmDate
Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease (NCT01877590)Wuhan General Hospital of Guangzhou Military Command2013-11-01
The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes (NCT01877603)Wuhan General Hospital of Guangzhou Military Command2013-07-01
Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease (NCT01863147)Wuhan General Hospital of Guangzhou Military Command2013-07-01
Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease (NCT01879293)Wuhan General Hospital of Guangzhou Military Command2013-07-01
Changes of Endothelial Function Before and After DSA in Patients With Diabetes (NCT01556984)Wuhan General Hospital of Guangzhou Military Command2012-10-01
Early Detection of Cognitive Dysfunction in Diabetes (NCT01830998)Wuhan General Hospital of Guangzhou Military Command2012-01-01
Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window (NCT01770197)Wuhan General Hospital of Guangzhou Military Command2008-01-01

Track Wuhan General Hospital of Guangzhou Military Command automatically

Every clearance here is in the API, with alerts when new ones post.